# Pizarra — PT-pseudo_1a4e0cf3b927 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_1a4e0cf3b927
Task: 1

Encounter: Urology - outpatient on 24 Feb 2025.
Referrer: Dr. R. van den Berg (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 74-year-old male
  - PSA: 7.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.427 ng/mL²
  - PSA velocity: 1.15 ng/mL/yr
  - Prior PSA: 6.3 ng/mL
  - Prostate volume: 16.4 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8631027 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: Iodinated contrast (mild)
  - Additional notes: PSA 7 ng/mL. PI-RADS 5. PSAD 0.43. Prostate volume 16 mL. DRE nodus. csPCa 0.86.

Vitals: weight 84 kg, height 175 cm, BMI 27.4, BP 116/70 mmHg, HR 56 bpm. Smoking: Current smoker (37 pack-yr).

Chief complaint: Persistent elevation of prostate-specific antigen alongside a history of biopsy-confirmed malignancy prompted this clinical review.

History: A 74-year-old married tram driver who shares a home with his partner came to attention after routine primary care screening flagged a rising prostate-specific antigen level. He endorses mild lower urinary tract symptoms, tallying an IPSS of 6, characterized by slight nocturia and a weak stream, while explicitly denying pelvic pain or hematuria. Daily walks lasting 45 minutes sustain his activity level, and he abstains from alcohol entirely. A 37 pack-yr smoking history remains on record. Aside from a 2011 laparoscopic cholecystectomy, his medical background is clear. He notes occasional knee stiffness from prolonged standing on the tram platform, though swelling or inflammatory signs are absent. An Arabic interpreter will be present at our upcoming consultation to guarantee precise communication.

Physical examination: DRE — texture: firm, irregular Nodus (~1.5 cm) in the right lateral lobe; mobility: fixed; asymmetry: localized to the right, with the remainder of the gland maintaining symmetric architecture. General inspection reveals no abnormalities. Cardiovascular and respiratory auscultation are clear. Peripheral lymph nodes are non-palpable, and hepatosplenomegaly is absent. Vital signs register at 116/70 mmHg blood pressure and 56 beats per minute heart rate. Body mass index stands at 27.4 kg/m².

Patient info: tram driver; Married; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Walking 45 min/day; IPSS score: 6/35 (mild LUTS).

Recent other appointments: Podiatry — routine foot care.
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: NO BIOPSY
  p(biopsy = yes) = 0.50 +/- 0.21   (95% CI 0.11-0.88)

Where the uncertainty comes from:
  - aleatoric  dA = 0.17  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.12  (few labelled cases resemble this one)
  - 5.4 effective neighbours out of 10; 2 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {no}

TIER 'discuss': A +/- dA straddles 0.5. The classifier genuinely CANNOT tell these two answers apart; measured accuracy in this tier is 0.61, barely above the 0.62 majority-class rate. Its number is a starting point only, and the case must be decided on the clinical evidence retrieved by the other participants.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=5.0, bx_ord=3.0, psa=7.0, age=74.0, psad=0.427, dre_ord=1.0, vol=16.4, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
  The statistical recommender relied only on the structured panel. It could not weigh the patient's PSA velocity (1.15 ng/mL/yr) against the high PI-RADS score (5) and the prior positive biopsy status. It also could not incorporate the specific details from the mpMRI report or the full PSA history trend, which are crucial for risk stratification.

WHY THE SUGGESTION COULD BE WRONG
  The prior suggests 'NO BIOPSY' with a wide interval (0.50 +/- 0.21), indicating high uncertainty. A failure mode is the conflict between the high csPCa predicted probability (0.8631027) and the DRE finding of 'Nodus' (which is ambiguous) and the prior positive biopsy status. Another failure mode is that the prior ignores the PSA velocity (1.15 ng/mL/yr), which suggests rapid progression, potentially overriding the PI-RADS score.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
  <document> radiology / mpMRI report -> If the report confirms high-grade features or specific lesion characteristics, it would increase the likelihood of biopsy.
  <document> PSA history (trend) -> If the trend shows a steeper rise or a more concerning trajectory, it would increase the likelihood of biopsy.
  <document> previous GP / urology consultation notes -> These notes might contain context regarding the initial diagnosis or follow-up plans that influence the current decision.
  <document> laboratory results (full panel) -> This could provide context on other markers that might influence the risk assessment.

## [4] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
  One block per document you opened. Quote the values and phrases that matter, verbatim and with units. Numbers, lesion descriptions, dates, explicit radiologist or clinician recommendations. Do not paraphrase a number. If a document turned out to be uninformative, say so in one line.

  **radiology / mpMRI report**
  {"case_id": "PT-pseudo_1a4e0cf3b927", "radiology_report": "Subject: Multiparametric MRI Prostate | Date: 12 February 2025 | Facility: Bravis Ziekenhuis\n\nClinical Context:\nA 74-year-old male with a documented PSA of 7.0 ng/mL and a prior biopsy bucket \"Positive\" for ISUP GG 2 disease. Scan ordered to reassess for active malignancy.\n\nFINDINGS:\nProstate volume measures 16.4 mL. T2-weighted sequences highlight a sharply demarcated, markedly hypointense focus spanning roughly 18 x 15 x 12 mm within the right mid-gland peripheral zone. Diffusion-weighted imaging shows pronounced restriction, mirrored by low ADC signal. Dynamic contrast studies capture early, focal, and intense enhancement against the adjacent parenchyma. Capsular integrity remains intact with no extraprostatic extension or seminal vesicle invasion. Pelvic lymph nodes appear normal in size and shape. Bone marrow signals are unremarkable.\n\nIMPRESSION:\nPI-RADS 5 lesion in the right mid-gland peripheral zone, highly suspicious for clinically significant prostate cancer.\nPSA density: 0.427 ng/mL/mL.\ncsPCa predicted probability 0.8631027."}

  **psa_trend**
  {"case_id": "PT-pseudo_1a4e0cf3b927", "psa_trend": [{"date": "Mar 2022", "val": 3.1}, {"date": "Dec 2022", "val": 1.1}, {"date": "Sep 2023", "val": 5.6}, {"date": "May 2024", "val": 4.5}, {"date": "Feb 2025", "val": 7.0}]}

  **previous_notes**
  {"case_id": "PT-pseudo_1a4e0cf3b927", "previous_notes": [{"date": "29 Jun 2024", "author": "Dr. R. van den Berg (GP)", "text": "The most recent measurement from May 2024 recorded a PSA of 6.3 ng/mL, continuing a steady climb since initial detection. All routine bloods and liver function tests remain within acceptable limits for his age. A urology follow-up has been booked to review the persistent elevation and prior histological confirmation."}]}

  **laboratory_results**
  {"case_id": "PT-pseudo_1a4e0cf3b927", "laboratory_results": [{"name": "PSA", "val": "7.0 ng/mL", "date": "12 Jan 2025", "flag": "H"}, {"name": "Free PSA", "val": "1.20 ng/mL", "date": "12 Jan 2025", "flag": ""}, {"name": "%Free PSA", "val": "17%", "date": "12 Jan 2025", "flag": "L"}, {"name": "Haemoglobin", "val": "14.9 g/dL", "date": "12 Jan 2025", "flag": ""}, {"name": "WBC", "val": "7.2 x10^9/L", "date": "12 Jan 2025", "flag": ""}, {"name": "Platelets", "val": "165 x10^9/L", "date": "12 Jan 2025", "flag": ""}, {"name": "Creatinine", "val": "87 umol/L", "date": "12 Jan 2025", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "12 Jan 2025", "flag": ""}, {"name": "Testosterone", "val": "15.8 nmol/L", "date": "12 Jan 2025", "flag": ""}, {"name": "Alkaline phosphatase", "val": "61 U/L", "date": "12 Jan 2025", "flag": ""}, {"name": "LDH", "val": "182 U/L", "date": "12 Jan 2025", "flag": ""}]}

NOT RETRIEVED
  get_family_history: Not called because the retrieval economy suggests it is not necessary for this specific decision based on the other retrieved data.

WHAT THE EVIDENCE SUPPORTS
  FOR sampling this patient now:
  PI-RADS 5 lesion in the right mid-gland peripheral zone
  PSA velocity of 1.15 ng/mL/yr
  csPCa predicted probability of 0.8631027

  AGAINST sampling this patient now:
  Prior biopsy status: Positive
  DRE finding: Nodus (Ambiguous)

WHERE THIS LEANS
  The retrieved evidence strongly argues for sampling due to the high PI-RADS score and rising PSA velocity, which aligns with the LLM-1-GAP-ANALYST's concern about the prior ignoring these factors. This leans toward a recommendation for biopsy.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [5] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [6] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the evidence strongly supports sampling due to the PI-RADS 5 lesion and a rising PSA velocity of 1.15 ng/mL/yr. This is supported by the high csPCa predicted probability of 0.8631027 and the prior positive biopsy status, which mandates re-evaluation. The statistical prior suggested deferral, but the retrieved evidence of high-risk imaging features and rapid PSA progression overrides this initial suggestion.

Variables that carried weight: bx=decisive, age=noted, dre=noted, psa=decisive, vol=noted, psad=important, pirads=decisive
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
